Researchers are exploring new ways to protect neurons, promote repair, and better track neurological disease. In spinal cord injury, Macamide B reduced motor neuron loss, scarring, and inflammatory cell death while restoring autophagy through improved lysosomal function. In peripheral nerve injury, cannabidiol promoted nerve repair through a gut–nerve pathway involving Akkermansia muciniphila, a gut-derived metabolite, and reduced Schwann cell inflammation.
A third study focused on Alzheimer’s disease, examining blood-based tau biomarkers that could help stage disease and predict progression. Together, these studies highlight how treatments targeting cellular repair and inflammation can complement better tools for monitoring neurodegeneration. The broader goal is to improve both how neurological damage is treated and how disease progression is identified over time.
1. Macamide B alleviates neuronal pyroptosis in spinal cord injury by activating acid ceramidase to inhibit lysosome membrane permeabilization
Macamide B reduced motor neuron loss, glial scarring, and inflammatory cell death in a mouse model of spinal cord injury. It also restored autophagy by stabilizing lysosomal function, pointing to acid ceramidase activation as a potential strategy for improving neurological recovery.
2. Mechanisms by which cannabidiol promotes peripheral nerve regeneration
In a mouse model of peripheral nerve injury, cannabidiol improved nerve repair, reduced muscle atrophy, and restored the gut bacterium Akkermansia muciniphila. The benefits were linked to a gut-derived metabolite that reduced Schwann cell inflammation, revealing a potential gut–nerve pathway for promoting regeneration.
3. Plasma eMTBR-tau243 and p-tau205 as T2 biomarkers for biological staging and prognosis in Alzheimer’s disease
Researchers found that plasma eMTBR-tau243 closely tracked later-stage tau buildup and cognitive decline in Alzheimer’s disease. Combined with p-tau217, it may help stage disease, predict progression, and guide treatment decisions using a blood test.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
